United States: Northern District Of California Dismisses A Putative Securities Class Action Against A Biopharmaceutical Company Related To Its Flagship Cancer Drug In Development - Shearman & Sterling LLP
On December 30, 2020, Judge Haywood S. Gilliam of the United States District Court for the Northern District of California granted a motion to dismiss a putative class action against a...
Full Article